Answers are grounded in this paper and cite their sources.
The number of inflammatory bowel disease (IBD) nurses and the amount of biological therapies being used in IBD has proliferated over the past ten years. Coordinating and managing a biologics service requires highly skilled specialist nursing knowledge and awareness of the support, assessment, administration and monitoring required in supporting the patient through this pathway. This article explores the role of the nurse and clinical issues in managing patients receiving biological therapies.
No takes yet. Share an insight, caveat, or question.
Greveson et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: